Alpha BreakingAlpha Breaking
Bullish Sentiment

PDLH: REJUVANT OUTPERFORMS ALL TESTED SUPPLEMENTS, INCLUDING STANDARD AKG AND NAD+ IN LANDMARK AGING CELL STUDY

|Thursday, May 28, 2026 at 8:03 AM ET
PDLH: REJUVANT OUTPERFORMS ALL TESTED SUPPLEMENTS, INCLUDING STANDARD AKG AND NAD+ IN LANDMARK AGING CELL STUDY

Share this article

Spread the word on social media

Latest Updates

May 28, 10:38 AM

REJUVANT OUTPERFORMS ALL TESTED SUPPLEMENTS, INCLUDING STANDARD AKG AND NAD+ IN LANDMARK AGING CELL STUDY

FERNANDINA BEACH, Fla., May 28, 2026 /PRNewswire/ -- Ponce De Leon Health (PDLH), a commercial stage longevity company focused on the extension of healthspan and the reduction of biologic age in humans and animals, today highlighted the publication of a landmark peer-reviewed study in the...

Source: PR Newswire
May 28, 10:38 AM

REJUVANT OUTPERFORMS ALL TESTED SUPPLEMENTS, INCLUDING STANDARD AKG AND NAD+ IN LANDMARK AGING CELL STUDY

FERNANDINA BEACH, Fla., May 28, 2026 /PRNewswire/ -- Ponce De Leon Health (PDLH), a commercial stage longevity company focused on the extension of healthspan and the reduction of biologic age in humans and animals, today highlighted the publication of a landmark peer-reviewed study in the...

Source: PR Newswire

Sources

Trade this headline in Alpha Contests.

Free practice contests — earn Alpha Coins
Enter a Contest

Stay Ahead of the Market

Get breaking news on trending finance topics delivered as they happen. We find the stories others miss.

More Breaking News

Disclaimer: StockAlpha.ai content is for informational and educational purposes only. It is not personalized investment advice. Sentiment ratings and market analysis reflect data-driven observations, not buy, sell, or hold recommendations. Always consult a qualified financial advisor before making investment decisions. Past performance does not guarantee future results.